Tag: Attrax
NuVasive announces expanded indications of use for Attrax Putty
NuVasive has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax Putty with its...
Study supports use of Attrax Putty as substitute for autograft
NuVasive has announced the results of a study supporting the use of Attrax Putty as a standalone bone graft substitute for autograft in instrumented...